Abstract
Infection is usually considered as the main cause of acute exacerbation in chronic obstructive pulmonary disease (COPD). However, uncertainty persists concerning the exact role of bacterial and viral infection in this setting because of the confusing and conflicting data on the role of tracheobronchial microflora and the usefulness of antibiotics in treating this disease. Most COPD patients have evidence of lower respiratory tract chronic bacterial colonization during remission periods as well as during acute exacerbations. This is evidenced by using microbiological analysis of secretions which reflect all the respiratory tract (sputum), the lower respiratory tract (transtracheal aspiration) or the distal respiratory tract (protected specimen brush, PSB). Potentially pathogenic organisms can be recovered from the respiratory tract secretions of virtually all patients with COPD at some time during the course of their disease. Absence of a difference between remission periods and acute exacerbations suggests that bacterial infection is probably not the predominant cause of acute exacerbations in COPD. In contrast, data indicate that the association between viral infections and acute exacerbations is clearer than that with bacteria, affecting probably more than 20% of cases.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Hudson LD (1989) Survival data in patients with acute and chronic lung disease requiring mechanical ventilation. Am Rev Respir Dis 140: S19–S24.
Murphy TF, Sethi S (1992) Bacterial infection in chronic obstructive pulmonary disease. Am Rev Respir Dis 146:1067–1083.
Tager I, Speizer FE (1975) Role of infection in chronic bronchitis. N Engl J Med 292:563–571.
Derenne JP, Fleury B, Pariente R (1988) Acute respiratory failure and chronic obstructive pulmonary disease. Am Rev Respir Dis 138:1006–1033.
Burrows B, Earle RH (1969) Course and prognosis of chronic obstructive lung disease. N Engl J Med 280:397–404.
May JR (1953) The bacteriology of chronic bronchitis. Lancet 2:534–537.
Stuart-Harris CH (1968) The role of bacterial and viral infection in chronic bronchitis. Arch Environ Health 16:586–595.
Brown CC Jr (1958) Chronic bronchitis and emphysema. Am J Med 17:478–484.
Miller DL, Jones R (1964) The bacterial flora of the upper respiratory tract and sputum of working-men. J Path Bact 87:182–185.
McHardy VU, Inglis JM, Calder MA, Crofton JW (1980) A study of infective and other factors in exacerbations of chronic bronchitis. Br J Dis Chest 74:228–238.
Lees AW, McNaught W (1959) Bacteriology of lower-respiratory-tract secretions, sputum, and upper-respiratory-tract secretions in ‘normals’ and chronic bronchitics. Lancet 2: 1112–1115.
Laurenzi GA, Potter RT, Kass EH (1961) Bacteriologic flora of the lower respiratory tract. N Engl J Med 265:1273–1278.
Haas H, Morris JF, Samson S, Kilbourn JP, KIM PJ (1977) Bacterial flora of the respiratory tract in chronic bronchitis: comparison of transtracheal fiberbronchoscopic, and oropharyngeal sampling methods. Am Rev Respir Dis 116:41–47.
Schreiner A, Bjerkestrand G, Digranes A, Halvorsen FJ, Kommerdal TM (1978) Bacteriological findings in the transtracheal aspirate from patients with acute exacerbation of chronic bronchitis. Infection 6:54–56.
Fagon JY, Chastre J, Trouillet JL, et al (1990) Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. use of the protected specimen brush technique in 54 mechanically ventilated patients. Am Rev Respir Dis 142:1004–1008.
Monso E, Ruiz J, Rosell A, Manterola J, Fiz J, Morera J, Ausina V (1995) Bacterial infection in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 152:1316–1320.
Soler N, Torres A, Ewig S, et al (1998) Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am Respir Crit Care Med 157:1498–1505.
Calder MA, Schonell ME (1971) Pneumococcal typing and the problem of endogenous or exogenous reinfection in chronic bronchitis. Lancet 1:1156–1159.
Smith CB, Kanner RE, Golden CA, Renzetti AD (1976) Haemophilus influenzae and Haemophilus parainfluenzae in chronic obstructive pulmonary disease. Lancet 11:1253–1255.
Nicotra B, Rivera M, Luman JI, Wallace RJ Jr (1986) Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease. Arch Intern Med 146:890–893.
Beaty CD, Grayston JT, Wang SP, Kuo CC, Reto CS, Martin TR (1991) Chlamydia pneumoniae, strain TWAR, infection in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 144:1408–1410.
Blasi F, Legnani D, Lombardo VM, et al (1993) Chlamydia pneumoniae infection in acute exacerbation of COPD. Eur Respir J 6:19–22.
Edelstein PH (1993) Legionnaires’ disease state of the art clinical article. Clin Infect Dis 16:741–749.
Griffith DE, Mazurek GH (1991) Pneumonia in chronic obstructive lung disease. Infect Dis Clin North Am 75:467–484.
Musher DM, Kubitschek KR, Crennan J, Baughn RE (1983) Pneumonia and acute febrile tracheobronchitis due to Haemophilus influenzae. Ann Intern Med 99:444–450.
Fang G, Fine M, Orloff J (1990) New and emerging etiologies for community-acquired pneumonia with implications for therapy: A prospective multicenter study of 359 cases. Medicine 69:307–316.
Torres A, Dorca J, Zalacain R, et al (1996) Community-acquired pneumonia in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 154:1456–1461.
McVay LV Jr, Sprunt DH (1953) Antibiotic prophylaxis in chronic respiratory disease. Arch Intern Med 92:833–846.
Buchanan J, Buchanan WW, Melrose AG, et al (1958) Long-term prophylactic administration of tetracycline for chronic bronchitis. Lancet 2:719–722.
Cherniak N, Vosti KL, Dowling HF, et al (1954) Long-term treatment of bronchiectasis and chronic bronchitis. Arch Intern Med 103:345–353.
Pridie RB, Datta N, Massey DG, et al (1960) A trial of continuous winter chemotherapy in chronic bronchitis. Lancet. 2:723–727.
Francis RS, May JR, Spicer CC (1961) Chemotherapy of bronchitis: influence of penicillin and tetracycline administered daily, or intermittent for exacerbations. Br Med J 2:979–985.
Davis AL, Grobow EJ, Tompsett R, McClement JH (1961) Bacterial infection and some effects of chemoprophylaxis in chronic pulmonary emphysema. I. Chemoprophylaxis with intermittent tetracycline. Am J Med 31:365–381.
Francis RES, Spicer CC (1960) Chemotherapy in chronic bronchitis. Br Med J 1:297–303.
Lepper MH, Dawling HF, Jackson GG, et al (1964) Natural history of placebo treated patients with chronic bronchial disease observed for 7 years. Antimicrob Agents Chemother 692-698.
Fletcher CM, Oldham PD (1966) Value of chemoprophylaxis and chemotherapy in early chronic bronchitis: a report to the medical research council by their working party on trials of chemotherapy in early chronic bronchitis. Br Med J 1:1317–1322.
Pines A (1967) Controlled trials of a sulphonamide given weekly to prevent exacerbations of chronic bronchitis. Br Med J 3:202–204.
Johnston RN, McNeill RS, Smith DH, et al (1969) Five-year winter chemoprophylaxis for chronic bronchitis. Br Med J 4:265–269.
Saint S, Bent S, Vittinghoff E, Grady D (1995) Antibiotics in chronic obstructive pulmonary disease exacerbations. JAMA 273:957–960.
Pines A, Raafat H, Greenfield JSB, Linsell WD, Solari ME (1972) Antibiotic regimens in moderately ill patients with purulent exacerbations of chronic bronchitis. Br J Dis Chest 66:107–115.
Anthonisen NR, Manfreda J, Warren CPW, et al (1987) Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 106:196–204.
Elmes PC, King TKC, Langlands JHM, et al (1965) Value of ampicillin in the hospital treatment of exacerbations of chronic bronchitis. Br Med J 2:904–908.
Petersen ES, Esmann V, Honcke P, Munkner C (1967) Controlled study of the effect of treatment on chronic bronchitis an evaluation using pulmonary function tests. Acta Med Scand 182: 293–305.
Nicotra MB, Rivera M, Awe RJ (1982) Antibiotic therapy of acute exacerbations of chronic bronchitis. Ann Intern Med 97:18–21.
Jorgensen AF, Coolidge J, Pedersen PA, et al (1992) Amoxicillin in treatment of acute uncomplicated exacerbations of chronic bronchitis. Scand J Prim Health Care 10:7–11.
Elmes PC, Fletcher CM, Dutton AAC (1957) Prophylactic use of oxytetracycline for exacerbations of chronic bronchitis. Br Med J 21:1272–1273.
Berry DG, Fry J, Hindley CP, et al (1960) Exacerbations of chronic bronchitis treatment with oxytetracycline. Lancet 1:137–139.
Fear EC, Edwards G (1962) Antibiotic regimes in chronic bronchitis. Br J Dis Chest 56:153–162.
American Thoracic Society (1995) Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. Am J Respir Crit Care Med 153:1711–1725.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Fagon, JY., Ract, C., Novara, A. (1999). The Role of Pulmonary Bacterial Infections in Severe Exacerbations of COPD Patients. In: Vincent, JL. (eds) Yearbook of Intensive Care and Emergency Medicine 1999. Yearbook of Intensive Care and Emergency Medicine, vol 1999. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-13453-5_15
Download citation
DOI: https://doi.org/10.1007/978-3-662-13453-5_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-65288-5
Online ISBN: 978-3-662-13453-5
eBook Packages: Springer Book Archive